C. Fortpied

发表

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

J. Blay, M. Sydes, A. Benson, 2015, European journal of cancer.

Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure

J. Kazmierska, V. Grégoire, M. Tomsej, 2021, Radiation oncology.

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925.

H. Bartelink, M. Guckenberger, F. van der Leij, 2021, Journal of the National Cancer Institute.

The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial.

H. Bartelink, V. Budach, M. Guckenberger, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial

V. Grégoire, I. Tinhofer, S. Quaglini, 2019, Front. Oncol..

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline

J. Raemaekers, A. Stamatoullas, P. Feugier, 2022, Haematologica.

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

J. Langendijk, G. Koutsodontis, É. Remenár, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial Running head Baseline metabolic tumor volume and early response in HL Authors

J. Raemaekers, O. Casasnovas, M. Federico, 2018 .

Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et al.

M. Federico, M. André, M. Meignan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of chemotherapy in 5 000 patients with head and neck cancer treated by curative surgery: a subgroup analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer

J. Pignon, V. Grégoire, Q. Le, 2020 .

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Long-term update of the 24954 EORTC phase III trial on larynx preservation.

V. Grégoire, J. Vermorken, L. Barzan, 2016, European journal of cancer.

EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

D. Lacombe, J. Bogaerts, J. Langendijk, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.

B. Jeremic, L. Collette, J. Pignon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial.

B. Coiffier, N. Mounier, P. Lugtenburg, 2012 .

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

É. Remenár, A. Awada, J. Buter, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Mediterranean Journal of Hematology and Infectious Diseases Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients We Retrospectively Collected Data from Hcl Patients Treated at the National Cancer Institute and Its Affiliated Center, Nasser

O. Khorshid, C. Fortpied, A. Namour, 2022 .

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

J. Raemaekers, M. Federico, C. Sebban, 2012 .

Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.

G. Salles, M. Ghielmini, T. Habermann, 2017, European journal of cancer.

OP-JNCI210114 1360..1368

H. Bartelink, V. Budach, M. Guckenberger, 2021 .

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led survey.

V. Grégoire, S. Tribius, S. Singer, 2021, Journal of geriatric oncology.

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma

O. Casasnovas, N. Mounier, M. Erlanson, 2017, Bone Marrow Transplantation.

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.

J. Pignon, V. Grégoire, J. Bourhis, 2019, Oral oncology.

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited

V. Grégoire, T. Pajak, J. Cooper, 2017, Cancer.

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Martin Hutchings, Annibale Versari, Umberto Ricardi, 2018, Blood.

TPF plus cetuximab (E) induction chemotherapy (ICT) followed by biochemoradiation (BCRT) with weekly E plus weekly cisplatin (P) or carboplatin (C) in stage III/IV squamous cell carcinoma of the head and neck (HNSCC): A randomized phase II EORTC trial.

É. Remenár, A. Awada, J. Buter, 2016 .

University of Groningen A Kinome RNAi Screen in Drosophila Identifies Novel Genes Interacting with Lgl, aPKC, and Crb Cell Polarity Genes in Epithelial Tissues

G. Koutsodontis, É. Remenár, A. Psyrri, 2017 .

The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials

C. Fortpied, M. Vinches, 2019, Front. Oncol..

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.

J. Machiels, I. Tinhofer, J. Canon, 2021, European journal of cancer.

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.

B. Jeremic, M. Parmar, J. Pignon, 2021, The Lancet. Oncology.

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.

J. Raemaekers, O. Casasnovas, P. Feugier, 2015, The Lancet. Haematology.

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

O. Casasnovas, P. Gobbi, E. Iannitto, 2020, Cancer medicine.

Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly: A phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment

D. de Jong, D. Jong, M. Debois, 2011 .

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.

J. Machiels, J. Bogaerts, I. Tinhofer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

B. Coiffier, F. Morschhauser, O. Casasnovas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.

Thomas Filleron, Murielle Mauer, Simone Mathoulin-Pélissier, 2013, European journal of cancer.

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

W. Wilson, V. Seshan, R. Advani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

OC-0374: Does low-dose TBI improve outcome in patients with early stage low grade NHL? (EORTC 20971-22997)

Cheng Soon Ong, L. Specht, B. Aleman, 2020 .

Relapse patterns in early‐PET negative, limited‐stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials

J. Raemaekers, J. Radford, M. Federico, 2022, British journal of haematology.

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.

E. van Limbergen, H. Bartelink, V. Budach, 2020, The Lancet. Oncology.

Gem‐(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non‐Hodgkin’s lymphoma – EORTC lymphoma group protocol 20021 (EudraCT number 2004‐004635‐54)

J. Raemaekers, I. Aurer, R. V. D. van der Maazen, 2011, European journal of haematology.

Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors

J. Briones, A. Bottomley, M. André, 2021, European journal of haematology.

STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

O. Casasnovas, N. Mounier, M. Erlanson, 2016 .

EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors.

H. Wildiers, M. Aapro, A. Ring, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21st Century

L. Collette, T. Gorlia, S. Litière, 2012 .

EORTC elderly task force position paper: approach to the older cancer patient.

D. Lacombe, H. Wildiers, P. Scalliet, 2010, European journal of cancer.

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials

M. Sydes, M. Federico, J. Franklin, 2017, Haematologica.

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

J. Machiels, L. De Cecco, S. Canevari, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups

M. Parmar, J. Pignon, V. Grégoire, 2017 .

Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925.

H. Bartelink, V. Budach, L. Boersma, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Using both clinical research and population-based cancer registry in long-term research- a case study using EORTC trials and the Dutch national cancer registry (IKNL)

L. Collette, O. Visser, A. Neven, 2020, Journal of Cancer Policy.

Design issues in head and neck clinical trials: a statistician's perspective

J. Bogaerts, C. Fortpied, C. Liberatoscioli, 2011, Anti-cancer drugs.

T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial

A. Diepstra, A. Loft, A. Arens, 2022, HemaSphere.

A quality control study on involved node radiotherapy in the EORTC/LYSA/FIL H10 Trial on stages I/II Hodgkin lymphoma; lessons learned.

J. Raemaekers, M. Federico, M. André, 2023, International Journal of Radiation Oncology, Biology, Physics.

RELAPSES IN INTERIM PET NEGATIVE LIMITED STAGE HODGKIN LYMPHOMA PATIENTS RECEIVING ABVD WITH OR WITHOUT RADIOTHERAPY–ANALYSIS OF EORTC/FIL/LYSA H10 AND UK NCRI RAPID TRIALS

J. Raemaekers, J. Radford, M. Federico, 2021, Hematological Oncology.

Evolution of recurrent asthma event rate over time in frailty models

Luc Duchateau, Paul A. J. Janssen, Iva Kezic, 2003 .

Personalized biomarker-based treatment strategy for patients with squamous cell carcinoma of the head and neck: EORTC position and approach.

J. Machiels, J. Bogaerts, I. Tinhofer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study.

M. Scorsetti, K. Stellamans, P. Ost, 2024, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results.

A. McWilliam, U. Nestle, C. Hurkmans, 2024, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.